Brasil - portuguès - ANVISA (Agência Nacional de Vigilância Sanitária)

momenta farmacÊutica ltda. - cloridrato de tramadol, paracetamol - analgesicos narcoticos

Brasil - portuguès - ANVISA (Agência Nacional de Vigilância Sanitária)

eurofarma laboratÓrios s.a. - cloridrato de tramadol, paracetamol - analgesicos narcoticos

Brasil - portuguès - ANVISA (Agência Nacional de Vigilância Sanitária)

supera farma laboratÓrios s.a - cloridrato de tramadol, paracetamol - analgesicos narcoticos

Brasil - portuguès - ANVISA (Agência Nacional de Vigilância Sanitária)

cosmed industria de cosmeticos e medicamentos s.a. - cloridrato de tramadol, paracetamol - analgesicos narcoticos

Brasil - portuguès - ANVISA (Agência Nacional de Vigilância Sanitária)

brainfarma indÚstria quÍmica e farmacÊutica s.a - cloridrato de tramadol, paracetamol - analgesicos narcoticos

Brasil - portuguès - ANVISA (Agência Nacional de Vigilância Sanitária)

zydus nikkho farmacÊutica ltda - cloridrato de tramadol, paracetamol - analgesicos narcoticos

Brasil - portuguès - ANVISA (Agência Nacional de Vigilância Sanitária)

eurofarma laboratÓrios s.a. - cloridrato de tramadol, paracetamol - analgesicos narcoticos

Unió Europea - portuguès - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Unió Europea - portuguès - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 para dados disponíveis em diferentes combinações).

Unió Europea - portuguès - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - neoplasias de estômago - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.